Hims & Hers Health, Inc. Goodwill & Intangibles Disclosure
| Carrying Value | ||||||||
| Balance at December 31, 2023 | $ | 110,881 | ||||||
| Addition from acquisitions | 1,847 | |||||||
| Balance at December 31, 2024 | 112,728 | |||||||
| Addition from acquisitions | 165,344 | |||||||
| Foreign currency translation adjustments | 253 | |||||||
| Balance at December 31, 2025 | $ | 278,325 | ||||||
| Gross Amount | Accumulated Amortization and Impairment | Net Carrying Value | Weighted Average Remaining Useful Life (Years) | |||||||||||||||||||||||
| Platform partnerships | $ | 99,964 | $ | (4,165) | $ | 95,799 | 11.5 | |||||||||||||||||||
| Trade names | 33,031 | (14,951) | 18,080 | 2.3 | ||||||||||||||||||||||
| 503B pharmacy license | 28,596 | (3,813) | 24,783 | 8.7 | ||||||||||||||||||||||
| Other | 69,208 | (11,754) | 57,454 | 3.1 | ||||||||||||||||||||||
| Intangible assets, net | $ | 230,799 | $ | (34,683) | $ | 196,116 | 7.8 | |||||||||||||||||||
| Gross Amount | Accumulated Amortization and Impairment | Net Carrying Value | Weighted Average Remaining Useful Life (Years) | |||||||||||||||||||||||
| 503B pharmacy license | $ | 28,596 | $ | (953) | $ | 27,643 | 9.7 | |||||||||||||||||||
| Trade names | 24,170 | (9,256) | 14,914 | 6.5 | ||||||||||||||||||||||
| Other | 4,786 | (3,933) | 853 | 6.0 | ||||||||||||||||||||||
| Intangible assets, net | $ | 57,552 | $ | (14,142) | $ | 43,410 | 8.5 | |||||||||||||||||||
| 2026 | $ | 40,952 | ||||||
| 2027 | 37,394 | |||||||
| 2028 | 23,262 | |||||||
| 2029 | 16,064 | |||||||
| 2030 | 13,667 | |||||||
| 2031 and thereafter | 64,777 | |||||||
| $ | 196,116 | |||||||
Want the next Hims & Hers Health, Inc. goodwill & intangibles disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Hims & Hers Health, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 23, 2026 | Showing above |
| 2024 | Feb 24, 2025 | |
| 2023 | Feb 26, 2024 | |
| 2022 | Feb 27, 2023 | |
| 2021 | Feb 24, 2022 | |
About Goodwill & Intangibles Disclosures
Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.
Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.